DFX Intelligence

Data Factory

RIA / WealthPrivate fundventure capital fund3(c)(1)3(c)(7)

EPSILON HEALTHCARE INNOVATION FUND II, LP

advised by EPSILON HEALTH INVESTORS, LLC

Delaware, United States

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:d206d4f9-ed3b-2e22-45ca-347b795383ce

Data as of Mar 28, 2024 (this record's last observation) from federal regulator filings. Page built Sep 19, 2026, 3:15 AM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 0
On other graphs: 1
Observed: Mar 30, 2023 to Mar 28, 2024
2 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Epsilon Healthcare Innovation Fund II, LP

Venture fund · shared adv fund id

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Adviser: EPSILON HEALTH INVESTORS, LLCCRD 298267
Fund type: Venture Capital Fund
Latest reported GAV: $12.5Mgross asset value on Schedule D 7.B(1), as of 2024-03-28; never fund size
Peak reported GAV: $12.5M
Beneficial owners: 17
Minimum investment: $100,000
Owned by the adviser: 1600%
Owned by funds of funds: 0%
Owned by non-US persons: 0%
Clients solicited: no
Form D file number: 021-465330an SEC offering identifier; the Form D vehicle on the venture or private equity graph is linked above when the identity layer has it
Organised in: Delaware, United States
First reported: Mar 30, 2023
Last reported: Mar 28, 2024fund reporting on the SEC extract ends 2024-12-31
Filings reporting it: 2
Fund id: 805-7991015873

Reported gross asset value by filing

each Schedule D 7.B(1) row as filed; GAV is gross asset value, never fund size

Filed	GAV	Owners	Minimum	Adviser owns	Audited	Name as filed
Mar 28, 2024	$12.5M	17	$100,000	1600.0%	no	EPSILON HEALTHCARE INNOVATION FUND II, LP
Mar 30, 2023	$8.8M	14	$100,000	1100.0%	no	EPSILON HEALTHCARE INNOVATION FUND II, LP

Custodians

Schedule D 7.B(1) question 25, as filed

Custodian	Legal name	City	State	Country	Related person	SEC number
Bank	JPMORGAN CHASE & CO.	NEW YORK	New York	United States	no	n/a
Bank	SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK	NEW YORK	New York	United States	no	n/a

Relationships

Advises (1)

← EPSILON HEALTH INVESTORS, LLCRegistered adviserVenture Capital Fund, ERA
Mar 30, 2023 to presentfactForm ADV

Dated events

No dated event names this entity yet.

Provenance

Graph: RIA / Wealth Management
Canonical id: dfx:ria:d206d4f9-ed3b-2e22-45ca-347b795383ce
First observed: Mar 30, 2023
Last observed: Mar 28, 2024 30 months ago
Source families: Federal regulator filings
1 registered feed stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

EPSILON HEALTHCARE INNOVATION FUND II, LP

advised by EPSILON HEALTH INVESTORS, LLC

Delaware, United States

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:d206d4f9-ed3b-2e22-45ca-347b795383ce

Data as of Mar 28, 2024 (this record's last observation) from federal regulator filings. Page built Sep 19, 2026, 3:15 AM UTC and rebuilt at most every 15 minutes.

Filed

GAV

Owners

Minimum

Adviser owns

Audited

Name as filed

Mar 28, 2024

$12.5M

$100,000

1600.0%

EPSILON HEALTHCARE INNOVATION FUND II, LP

Mar 30, 2023

$8.8M

$100,000

1100.0%

EPSILON HEALTHCARE INNOVATION FUND II, LP

Custodian

Legal name

City

State

Country

Related person

SEC number

Bank

JPMORGAN CHASE & CO.

NEW YORK

New York

United States

n/a

Bank

SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK

NEW YORK

New York

United States

n/a